| Dear Reader, When it comes to artificial intelligence...the investment world’s attention has been focused on the Clash of the Titans. OpenAI’s ChatGPT versus Microsoft’s new Bing versus Google’s Bard. But in the year where generative AI has infiltrated the public consciousness, something else has been permeating in the background... It’s something you need to know about now. Before the crowd gets wind... In the medtech space...a race is on to embed AI into healthcare. We think one small, ASX-listed company is well-positioned in this race. It may not win. It’s a very risky speculation at this stage. But even if it finishes in the top bunch, the gains could be astonishing. Click here to learn more. Regards, James Woodburn,
Publisher, Fat Tail Investment Research | 